Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies
2001; Wiley; Volume: 90; Issue: 10 Linguagem: Inglês
10.1111/j.1651-2227.2001.tb03257.x
ISSN1651-2227
AutoresMuhammad Totong Kamaluddin, Paul McNally, Fin Breatnach, Aengus O’Marcaigh, David Webb, Edward Odell, Paul Scanlon, K Butler, Anne O’Meara,
Tópico(s)Cancer therapeutics and mechanisms
ResumoEight consecutive paediatric patients with acute lymphoblastic leukaemia (ALL) ( n =7) and T‐cell non‐Hodgkin's lymphoma (NHL) ( n =1) presenting within a 5‐wk interval were started on a standard induction protocol which included weekly treatment with vincristine for 4 wk. Itraconazole was commenced as antifungal prophylaxis, 1–21 d after the first injection of vincristine. Within 2 to 4 wk, enhanced vincristine neurotoxicity was noted in all patients, abdominal cramps and constipation occurred most frequently, and one patient developed a bowel perforation associated with paralytic ileus. Hyponatraemia associated with SIADH was observed in three patients and four patients developed seizures. An additional patient with B cell NHL developed seizures 5 d after an injection of vincristine. Recovery was complete in all patients and ranged from 2 d to 15 wk. Conclusion : The extent and consistency of adverse effects documented in this study support the recommendation that concurrent administration of vincristine and itraconazole should be avoided.
Referência(s)